Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
Molecular Mass Fingerprinting
Molecular Mass Fingerprinting confirms the WOLVERINE recovery blend. The primary component BPC-157 (C62H98N16O22, theoretical average mass 1419.56 Da) was detected at observed neutral mass 1419.11 Da (-0.45 Da, within the +/-1.0 Da identity tolerance), with characteristic multiply-charged envelope [M+2H]2+ m/z ~710.6 and [M+H]+ m/z ~1420.1 under ESI+. The co-formulated second component TB-500 (Thymosin Beta-4, C212H350N56O78S, theoretical average mass 4963.51 Da) was independently confirmed by its own multiply-charged ion series ([M+5H]5+ ~993.7, [M+6H]6+ ~828.3). Both blend constituents, BPC-157 and TB-500, are present and mass-confirmed.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.